Hexobendine

This classification denotes a vasodilating agent with the molecular formula C30H44N2O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B6X4SYR93B, chemically known as 3,4,5-trimethoxybenzoic acid, diester with 3,3-(ethylenebis(methylimino))di-1-propanol but generally known as hexobendine, which bears US NIH Compound Identifier 5777. European Medicines Agency schedules Hexobendine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08039MIG. The term HEXOBENDINE is an International Non-Proprietary Name. World Health Organization schedules hexobendine in its Anatomical Therapeutic Chemical (ATC) Classification. HEXOBENDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule hexobendine under HS 29221980 and SITC 51461. As of Q4 2014, HEXOBENDINE remains the US FDA Preferred Term for this commodity. Hexobendine bears US NLM identifiers UMLS ID C0019471 and NCI Concept Code C83755. SMILES: O(CCCN(CCN(CCCOC(=O)c1cc(OC)c(OC)c(OC)c1)C)C)C(=O)c1cc(OC)c(OC)c(OC)c1.